Patents by Inventor Kori Wallace

Kori Wallace has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220259301
    Abstract: The present disclosure relates to methods of treating Crohn's disease or inducing remission of Crohn's disease in a subject. The present disclosure also relates to methods of treating ulcerative colitis or inducing remission of ulcerative colitis in a subject.
    Type: Application
    Filed: January 6, 2022
    Publication date: August 18, 2022
    Inventors: Kori Wallace, Anne M. Robinson, Ezequiel Neimark, Alexandra P. Song, Jasmina Kalabic, Bidan Huang, Xiaomei Liao, Graham A. Heap
  • Patent number: 8178509
    Abstract: The present invention provides a therapeutic method for treating an inflammatory response caused by a sickle cell crisis, comprising administration of an effective amount of an A2A adenosine receptor agonist. Optionally, the method includes administration of a type IV PDE inhibitor (e.g., rolipram).
    Type: Grant
    Filed: February 9, 2007
    Date of Patent: May 15, 2012
    Assignee: University of Virginia Patent Foundation
    Inventors: Joel M. Linden, Kori Wallace, Robert Alan Figler, Jayson M. Rieger
  • Publication number: 20080009460
    Abstract: The present invention provides a therapeutic method for treating an inflammatory response caused by a sickle cell crisis, comprising administration of an effective amount amount of an A2A adenosine receptor agonist. Optionally, the method includes administration of a type IV PDE inhibitor (e.g., rolipram).
    Type: Application
    Filed: February 9, 2007
    Publication date: January 10, 2008
    Inventors: Joel Linden, Kori Wallace, Robert Figler, Jayson Rieger